Sermorelin (5mg)

Sermorelin (5mg)

$79.99
$79.99
SAVE Sold out

✔ Verified 99+% Purity

✔ Third-Party Approved & Tested

✔ Fast Australian Shipping

Research Use Only

This product is sold for research purposes only. It is not intended for human or animal consumption. By purchasing this product, you confirm that you are a qualified researcher or are purchasing for legitimate research purposes.

Bacteriostatic Water (20mg)
Add Bacteriostatic Water (20mg)
Required for reconstitution
$24.99
Sermorelin (5mg)

Sermorelin (5mg)

$79.99
$79.99
SAVE Sold out

Shipping Information

Orders are processed and dispatched within 24 hours of payment confirmation (Monday–Friday). Delivery typically arrives within 1–4 business days via Standard post, and 1-2 business days via Express post.

View full details

Sermorelin

Supplied as a lyophilized (freeze-dried) white powder in a sealed sterile vial. Requires reconstitution with bacteriostatic water prior to use. Each vial contains 5mg of Sermorelin at ≥99% purity.

Sermorelin is a synthetic version of the natural signal your body uses to trigger growth hormone release. It replicates the first 29 amino acids of GHRH (growth hormone releasing hormone) — the portion of the molecule responsible for binding to pituitary receptors and activating the growth hormone pathway. Unlike modified analogues, Sermorelin uses the unmodified native sequence, making it a particularly clean research tool for studying GHRH receptor activity in its most natural form. It is one of the most extensively studied GHRH peptides in preclinical literature, with a well-documented profile covering receptor binding, downstream IGF-1 effects, and dose-response relationships.

Research Background

Research has extensively documented Sermorelin's effects on pituitary growth hormone release, including dose-response relationships, receptor binding kinetics, and downstream effects on IGF-1. Studies have also compared Sermorelin with modified GHRH analogues to understand how specific amino acid changes affect stability, potency, and receptor selectivity — work that helps characterise the structure-activity relationships of GHRH peptides and informs the development of novel analogues.

Key Research Areas
Pituitary growth hormone secretion models
GHRH receptor binding and activation studies
IGF-1 downstream signalling research
Hypothalamic-pituitary axis signalling
Age-related hormonal dynamics and endocrine modulation
Structure-activity comparison with GHRH analogues
Studied Mechanisms
GHRH receptor agonism via native unmodified sequence
Stimulation of endogenous GH release from the pituitary
IGF-1 upregulation in hepatic and peripheral tissue models
cAMP signalling pathway activation
Dose-response characterisation of GH pulse dynamics

Product Specifications

Molecular FormulaC₁₄₉H₂₄₆N₄₄O₄₂S
Molecular Weight3,357.9 g/mol
SequenceGHRH(1-29) — Native human sequence
AppearanceLyophilized Powder
Purity≥99% (HPLC Verified)
StorageStore at -20°C, away from light and moisture
Research Use Only

This product is strictly intended for in vitro laboratory research purposes only. It is not approved for human or veterinary use, and is not intended for consumption, injection, or any therapeutic application.